News

Panelists discuss how comprehensive patient education about expected adverse effects, combined with prophylactic measures ...
Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.
For patients who have progressed on endocrine therapy, consistent monitoring of blood counts and biomarker testing informs ...
Step-up dosing with remote monitoring resulted in 47% of patients receiving bispecific antibodies remaining outpatient, even ...
The selective internal radiation therapy SIR-Spheres has been approved by the FDA for use in patients with unresectable ...
Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how ...
Panelists highlight that being a care partner is one of the most challenging roles, requiring emotional resilience, ...
Volumetric PET biomarkers may help predict risk of toxicity from CAR T-cell therapy in patients with large B-cell lymphoma, ...